These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28262680)

  • 1. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
    Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
    Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
    Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
    PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and veterinary trypanocidal benzoxaboroles target CPSF3.
    Wall RJ; Rico E; Lukac I; Zuccotto F; Elg S; Gilbert IH; Freund Y; Alley MRK; Field MC; Wyllie S; Horn D
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9616-9621. PubMed ID: 30185555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
    Sonoiki E; Palencia A; Guo D; Ahyong V; Dong C; Li X; Hernandez VS; Zhang YK; Choi W; Gut J; Legac J; Cooper R; Alley MR; Freund YR; DeRisi J; Cusack S; Rosenthal PJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4886-95. PubMed ID: 27270277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting
    Palencia A; Bougdour A; Brenier-Pinchart MP; Touquet B; Bertini RL; Sensi C; Gay G; Vollaire J; Josserand V; Easom E; Freund YR; Pelloux H; Rosenthal PJ; Cusack S; Hakimi MA
    EMBO Mol Med; 2017 Mar; 9(3):385-394. PubMed ID: 28148555
    [No Abstract]   [Full Text] [Related]  

  • 9. Radicicol confers mid-schizont arrest by inhibiting mitochondrial replication in Plasmodium falciparum.
    Chalapareddy S; Bhattacharyya MK; Mishra S; Bhattacharyya S
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4341-52. PubMed ID: 24841259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
    Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
    Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum Atg18 localizes to the food vacuole via interaction with the multi-drug resistance protein 1 and phosphatidylinositol 3-phosphate.
    Sudhakar R; Das D; Thanumalayan S; Gorde S; Sijwali PS
    Biochem J; 2021 May; 478(9):1705-1732. PubMed ID: 33843972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking of the signature protein of intra-erythrocytic Plasmodium berghei-induced structures, IBIS1, to P. falciparum Maurer's clefts.
    Petersen W; Matuschewski K; Ingmundson A
    Mol Biochem Parasitol; 2015; 200(1-2):25-9. PubMed ID: 25956941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome
    Blake LD; Johnson ME; Siegel SV; McQueen A; Iyamu ID; Shaikh AK; Shultis MW; Manetsch R; Kyle DE
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
    Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
    Malar J; 2011 May; 10():119. PubMed ID: 21554743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
    Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Freund YR; Berry P; Ciaravino V; Erve JCL; Rosenthal PJ; Campo B; Gamo FJ; Sanz LM; Cao J
    J Med Chem; 2017 Jul; 60(13):5889-5908. PubMed ID: 28635296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites.
    Frame IJ; Deniskin R; Rinderspacher A; Katz F; Deng SX; Moir RD; Adjalley SH; Coburn-Flynn O; Fidock DA; Willis IM; Landry DW; Akabas MH
    ACS Chem Biol; 2015 Mar; 10(3):775-83. PubMed ID: 25602169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzothiophene carboxamide derivatives as novel antimalarials.
    Banerjee T; Kapoor N; Surolia N; Surolia A
    IUBMB Life; 2011 Dec; 63(12):1111-5. PubMed ID: 22038932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.